Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 50 Melanoma 23 Neoplasms 19 Neoplasm Metastasis 19 Squamous Cell Carcinoma of Head and Neck 17 Lung Neoplasms 13 Skin Neoplasms 12 Recurrence 10 Head and Neck Neoplasms 10 Carcinoma, Renal Cell 9 Prostatic Neoplasms 8 Ovarian Neoplasms 8 Colorectal Neoplasms 8 Carcinoma, Squamous Cell 8 Carcinoma, Basal Cell 8 Breast Neoplasms 8 Urinary Bladder Neoplasms 7 Carcinoma, Merkel Cell 7 Triple Negative Breast Neoplasms 6 Colonic Neoplasms 6 Carcinoma 6 Adenocarcinoma 6 Uterine Cervical Neoplasms 5 Sarcoma 5 Pancreatic Neoplasms 5 Glioblastoma 5 Stomach Neoplasms 4 Multiple Myeloma 4 Mouth Neoplasms 4 Fallopian Tube Neoplasms 4

Interventions

Cisplatin 6 pembrolizumab 5 fludarabine 5 Nivolumab 5 Cyclophosphamide 5 aldesleukin 4 Paclitaxel 4 Magnetic Resonance Spectroscopy 4 Ifosfamide 4 Radiotherapy 3 Ipilimumab 3 fludarabine phosphate 2 entinostat 2 cabozantinib 2 avelumab 2 aflibercept 2 Specimen Handling 2 CTLA-4 Antigen 2 Biopsy 2 Adoptive Transfer 2 vinflunine 1 toripalimab 1 rocakinogene sifuplasmid 1 ripretinib 1 oncogene protein E7, Human papillomavirus type 16 1 niraparib 1 nimotuzumab 1 lenvatinib 1 enfortumab vedotin 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Penile Neoplasms × cemiplimab × Clear all

NCT07101822 2025-08-03

BRAVA PENILE

Hospital Israelita Albert Einstein

Phase 2 Not yet recruiting

Penile Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡